WINSTON-SALEM, NC - 08-31-2017 (Press Release Jet) --
Charter Medical Ltd., a globally recognized manufacturer of products for the regenerative medicine, blood management, and bioprocessing industries, unveiled a modernized identity this morning reflecting the company’s growing areas of expertise.
A simple color coded icon system will help our customers recognize each area of our business. Blue represents Bioprocessing and red represents Blood Management. Decades of experience in these two fields have allowed us to release new products that cater to the Regenerative Medicine industry. Symbolically, by combining blue and red, this portion of our business will be expressed with the color purple.
A monogram of Charter Medicals initials will serve as our new logo symbol. The C is depicted with the iconic shade of “Charter Blue,” the same blue that has been used to identify our brand for over 25 years. The heartbeat M, shown in all three colors, represents the heartbeat of the patients our products impact. The incorporation of all three colors in our logo symbol, portrays all three areas of our business that enable Charter Medical to provide products that will help personalized medicine become a reality.
“This rebranding will serve as a bridge between our traditional businesses and the promising fields of cell and gene therapy and bioprocessing. The new logo modernizes our graphical representation as we continue to modernize the company. Now, customers will have a symbol that will allow them to easily identify Charter Medical as a key supplier for the markets we serve,” said Gaël Peron, President at Charter Medical.
More information on this rebranding and the selection of this logo can be found at http://chartermedical.com/charter-medical-announces-completion-major-rebranding-initiative/
About Charter Medical, Ltd
Charter Medical helps produce safe and effective medicines by designing and manufacturing single-use solutions for regenerative medicine, bioprocessing, and blood management markets. Charter Medical is a wholly owned subsidiary of Fenner PLC (LSE:FENR) and operates out of an ISO 13485 certified and FDA registered manufacturing facility in Winston-Salem, NC. To learn more, visit http://www.chartermedical.com.
For the original news story, please visit https://pressreleasejet.com/news/charter-medical-announces-completion-of-major-rebranding-initiative.html.
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com